2018
DOI: 10.1007/s00520-018-4288-9
|View full text |Cite
|
Sign up to set email alerts
|

Complementary and alternative medicine (CAM) information and support needs of Chinese-speaking cancer patients

Abstract: CSCPs reported using CAM at rates significantly higher than for non-CSCPs. Given the predominance of biological-based therapies and the lack of consultation with oncology HCPs, it is imperative that CAM use be assessed and documented to ensure CSCPs' safety during cancer treatment. Culturally appropriate information and decision support is required to ensure that CSCPs are making safe and informed CAM decisions.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
23
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(24 citation statements)
references
References 30 publications
1
23
0
Order By: Relevance
“…participants that are needed. This sample size is consistent with other interpretive description studies of clinical populations (Balneaves et al, 2018;Grattan et al, 2018;Kolltveit et al, 2017).…”
Section: Data Collectionsupporting
confidence: 91%
“…participants that are needed. This sample size is consistent with other interpretive description studies of clinical populations (Balneaves et al, 2018;Grattan et al, 2018;Kolltveit et al, 2017).…”
Section: Data Collectionsupporting
confidence: 91%
“…About 54% of participants reported having anxiety and 89% of those touch therapies. (18) With the increasing immigration trends globally, the possibility of cultural influences related to touch therapies and other integrative oncology practices should be expected, and offers an area for future research.…”
Section: Resultsmentioning
confidence: 99%
“…The names of 13 individual cancer types were specified in the studies, of which breast cancer received the most attention. Many studies, 3,4,8,9,11,12,14,16,17,19,23,33,36,37,41,42,44,45,49,50,53,56,59,[64][65][66]68,72,74] Prostate 14% [5,8,14,16,20], [51] (prostate vs. other), [56] (and other male reproductive), [58] (review), [60,66,73,74] Gynecological 9% [14,16] (uterine), [32] (ovarian vs./others), [36] (cervical), [55] (cervical), [56,62,66] Colorectal/colon/bowel 9%…”
Section: Resultsmentioning
confidence: 99%